(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(Z)-2-[3-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethenyl]phenoxy]oxane-3,4,5-triol

Details

Top
Internal ID 954db874-5e9f-4fa8-81d3-57de82b25c9d
Taxonomy Phenylpropanoids and polyketides > Stilbenes > Stilbene glycosides
IUPAC Name (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(Z)-2-[3-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethenyl]phenoxy]oxane-3,4,5-triol
SMILES (Canonical) C1=CC(=CC=C1C=CC2=CC(=CC(=C2)OC3C(C(C(C(O3)CO)O)O)O)O)OC4C(C(C(C(O4)CO)O)O)O
SMILES (Isomeric) C1=CC(=CC=C1/C=C\C2=CC(=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O
InChI InChI=1S/C26H32O13/c27-10-17-19(30)21(32)23(34)25(38-17)36-15-5-3-12(4-6-15)1-2-13-7-14(29)9-16(8-13)37-26-24(35)22(33)20(31)18(11-28)39-26/h1-9,17-35H,10-11H2/b2-1-/t17-,18-,19-,20-,21+,22+,23-,24-,25-,26-/m1/s1
InChI Key YGQPMDDXSJHKJT-GSNCJTLYSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C26H32O13
Molecular Weight 552.50 g/mol
Exact Mass 552.18429107 g/mol
Topological Polar Surface Area (TPSA) 219.00 Ų
XlogP -0.50
Atomic LogP (AlogP) -2.08
H-Bond Acceptor 13
H-Bond Donor 9
Rotatable Bonds 8

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(Z)-2-[3-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethenyl]phenoxy]oxane-3,4,5-triol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.8752 87.52%
Caco-2 - 0.8965 89.65%
Blood Brain Barrier + 0.6500 65.00%
Human oral bioavailability - 0.7571 75.71%
Subcellular localzation Mitochondria 0.6074 60.74%
OATP2B1 inhibitior - 0.5669 56.69%
OATP1B1 inhibitior + 0.9489 94.89%
OATP1B3 inhibitior + 0.9676 96.76%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.8500 85.00%
BSEP inhibitior - 0.5403 54.03%
P-glycoprotein inhibitior - 0.5527 55.27%
P-glycoprotein substrate - 0.9639 96.39%
CYP3A4 substrate - 0.5107 51.07%
CYP2C9 substrate + 0.5811 58.11%
CYP2D6 substrate - 0.8191 81.91%
CYP3A4 inhibition - 0.9327 93.27%
CYP2C9 inhibition - 0.9244 92.44%
CYP2C19 inhibition - 0.8678 86.78%
CYP2D6 inhibition - 0.9046 90.46%
CYP1A2 inhibition - 0.9434 94.34%
CYP2C8 inhibition + 0.4761 47.61%
CYP inhibitory promiscuity - 0.6893 68.93%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.9500 95.00%
Carcinogenicity (trinary) Non-required 0.5665 56.65%
Eye corrosion - 0.9939 99.39%
Eye irritation - 0.9001 90.01%
Skin irritation - 0.8513 85.13%
Skin corrosion - 0.9684 96.84%
Ames mutagenesis - 0.7300 73.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7675 76.75%
Micronuclear - 0.5641 56.41%
Hepatotoxicity - 0.9123 91.23%
skin sensitisation - 0.8415 84.15%
Respiratory toxicity - 0.7333 73.33%
Reproductive toxicity - 0.5333 53.33%
Mitochondrial toxicity - 0.7750 77.50%
Nephrotoxicity - 0.6933 69.33%
Acute Oral Toxicity (c) III 0.5643 56.43%
Estrogen receptor binding + 0.6651 66.51%
Androgen receptor binding - 0.5216 52.16%
Thyroid receptor binding + 0.5247 52.47%
Glucocorticoid receptor binding - 0.6624 66.24%
Aromatase binding + 0.6221 62.21%
PPAR gamma + 0.7938 79.38%
Honey bee toxicity - 0.7346 73.46%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.5700 57.00%
Fish aquatic toxicity + 0.7694 76.94%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.22% 91.11%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 94.08% 96.00%
CHEMBL226 P30542 Adenosine A1 receptor 93.38% 95.93%
CHEMBL3401 O75469 Pregnane X receptor 91.42% 94.73%
CHEMBL3194 P02766 Transthyretin 90.38% 90.71%
CHEMBL3137262 O60341 LSD1/CoREST complex 89.92% 97.09%
CHEMBL1293249 Q13887 Kruppel-like factor 5 89.20% 86.33%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 88.47% 86.92%
CHEMBL1806 P11388 DNA topoisomerase II alpha 88.07% 89.00%
CHEMBL3060 Q9Y345 Glycine transporter 2 87.66% 99.17%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 87.60% 95.56%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 85.12% 96.09%
CHEMBL1293255 P15428 15-hydroxyprostaglandin dehydrogenase [NAD+] 84.98% 83.57%
CHEMBL2581 P07339 Cathepsin D 83.97% 98.95%
CHEMBL5608 Q16288 NT-3 growth factor receptor 83.32% 95.89%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 81.87% 95.89%
CHEMBL2288 Q13526 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 81.34% 91.71%

Cross-Links

Top
PubChem 16040018
NPASS NPC234489
LOTUS LTS0174555
wikiData Q105348231